Diana de la Iglesia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Diana de la Iglesia has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Francisco Javier Martín-Sánchez
Hospital Clinico San Carlos
3 shared publications - Guillermo de la Calle
Universidad Politécnica de Madrid
3 shared publications - Stefano Chiesa
Dept Inteligencia Artificial, Facultad de Informática, Universidad Politécnica de Madrid, Campus de Montegancedo S/N, 28660 Boadilla del Monte, Madrid, Spain
3 shared publications Casimir Kulikowski
Department of Computer Science, Rutgers - The State University of New Jersey, Piscataway, New Jersey, United States of America
2 shared publicationsJosipa Kern
2 shared publications- Miguel García-Remesal
Biomedical Informatics Group, Department of Artificial Intelligence Escuela Técnica Superior de Ingenieros Informáticos, Universidad Politécnica de Madrid, Campus de Montegancedo s/n, 28660 Boadilla del Monte, Spain
2 shared publications
Latest Publications
- Open Access
- 27 October 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (10) , e110331
A Machine Learning Approach to Identify Clinical Trials Involving Nanodrugs and Nanodevices from ClinicalTrials.gov
Clinical Trials (CTs) are essential for bridging the gap between experimental research on new drugs and their clinical application. Just like CTs for traditional drugs and biologics have helped accelerate the translation of biomedical findings into medical practice, CTs for nanodrugs and nanodevices could advance novel nanomaterials as agents for diagnosis and therapy. Although there is publicly available information about nanomedicine-related CTs, the online archiving of this information is carried out without adhering to criteria that discriminate between studies involving nanomaterials or nanotechnology-based processes (nano), and CTs that do not involve nanotechnology (non-nano). Finding out whether nanodrugs and nanodevices were involved in a study from CT summaries alone is a challenging task. At the time of writing, CTs archived in the well-known online registry ClinicalTrials.gov are not easily told apart as to whether they are nano or non-nano CTs—even when performed by domain experts, due to the lack of both a common definition for nanotechnology and of standards for reporting nanomedical experiments and results. We propose a supervised learning approach for classifying CT summaries from ClinicalTrials.gov according to whether they fall into the nano or the non-nano categories. Our method involves several stages: i) extraction and manual annotation of CTs as nano vs. non-nano, ii) pre-processing and automatic classification, and iii) performance evaluation using several state-of-the-art classifiers under different transformations of the original dataset. The performance of the best automated classifier closely matches that of experts (AUC over 0.95), suggesting that it is feasible to automatically detect the presence of nanotechnology products in CT summaries with a high degree of accuracy. This can significantly speed up the process of finding whether reports on ClinicalTrials.gov might be relevant to a particular nanoparticle or nanodevice, which is essential to discover any precedents for nanotoxicity events or advantages for targeted drug therapy.
- 27 October 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (10) , e110331
Open AccessA Machine Learning Approach to Identify Clinical Trials Involving Nanodrugs and Nanodevices from ClinicalTrials.gov
Clinical Trials (CTs) are essential for bridging the gap between experimental research on new drugs and their clinical application. Just like CTs for traditional drugs and biologics have helped accelerate the translation of biomedical findings into medical practice, CTs for nanodrugs and nanodevices could advance novel nanomaterials as agents for diagnosis and therapy. Although there is publicly available information about nanomedicine-related CTs, the online archiving of this information is carried out without adhering to criteria that discriminate between studies involving nanomaterials or nanotechnology-based processes (nano), and CTs that do not involve nanotechnology (non-nano). Finding out whether nanodrugs and nanodevices were involved in a study from CT summaries alone is a challenging task. At the time of writing, CTs archived in the well-known online registry ClinicalTrials.gov are not easily told apart as to whether they are nano or non-nano CTs—even when performed by domain experts, due to the lack of both a common definition for nanotechnology and of standards for reporting nanomedical experiments and results. We propose a supervised learning approach for classifying CT summaries from ClinicalTrials.gov according to whether they fall into the nano or the non-nano categories. Our method involves several stages: i) extraction and manual annotation of CTs as nano vs. non-nano, ii) pre-processing and automatic classification, and iii) performance evaluation using several state-of-the-art classifiers under different transformations of the original dataset. The performance of the best automated classifier closely matches that of experts (AUC over 0.95), suggesting that it is feasible to automatically detect the presence of nanotechnology products in CT summaries with a high degree of accuracy. This can significantly speed up the process of finding whether reports on ClinicalTrials.gov might be relevant to a particular nanoparticle or nanodevice, which is essential to discover any precedents for nanotoxicity events or advantages for targeted drug therapy.
- 1 April 2013
- Published by Bentham Science Publishers Ltd. in Current Topics in Medicinal Chemistry
- Vol. 13 (5) , 526-575
The Impact of Computer Science in Molecular Medicine: Enabling High- Throughput Research
The Human Genome Project and the explosion of high-throughput data have transformed the areas of molecular and personalized medicine, which are producing a wide range of studies and experimental results and providing new insights for developing medical applications. Research in many interdisciplinary fields is resulting in data repositories and computational tools that support a wide diversity of tasks: genome sequencing, genome-wide association studies, analysis of genotype-phenotype interactions, drug toxicity and side effects assessment, prediction of protein interactions and diseases, development of computational models, biomarker discovery, and many others. The authors of the present paper have developed several inventories covering tools, initiatives and studies in different computational fields related to molecular medicine: medical informatics, bioinformatics, clinical informatics and nanoinformatics. With these inventories, created by mining the scientific literature, we have carried out several reviews of these fields, providing researchers with a useful framework to locate, discover, search and integrate resources. In this paper we present an analysis of the state-ofthe- art as it relates to computational resources for molecular medicine, based on results compiled in our inventories, as well as results extracted from a systematic review of the literature and other scientific media. The present review is based on the impact of their related publications and the available data and software resources for molecular medicine. It aims to provide information that can be useful to support ongoing research and work to improve diagnostics and therapeutics based on molecular–level insights.
- 1 April 2013
- Published by Bentham Science Publishers Ltd. in Current Topics in Medicinal Chemistry
- Vol. 13 (5) , 526-575
The Impact of Computer Science in Molecular Medicine: Enabling High- Throughput Research
The Human Genome Project and the explosion of high-throughput data have transformed the areas of molecular and personalized medicine, which are producing a wide range of studies and experimental results and providing new insights for developing medical applications. Research in many interdisciplinary fields is resulting in data repositories and computational tools that support a wide diversity of tasks: genome sequencing, genome-wide association studies, analysis of genotype-phenotype interactions, drug toxicity and side effects assessment, prediction of protein interactions and diseases, development of computational models, biomarker discovery, and many others. The authors of the present paper have developed several inventories covering tools, initiatives and studies in different computational fields related to molecular medicine: medical informatics, bioinformatics, clinical informatics and nanoinformatics. With these inventories, created by mining the scientific literature, we have carried out several reviews of these fields, providing researchers with a useful framework to locate, discover, search and integrate resources. In this paper we present an analysis of the state-ofthe- art as it relates to computational resources for molecular medicine, based on results compiled in our inventories, as well as results extracted from a systematic review of the literature and other scientific media. The present review is based on the impact of their related publications and the available data and software resources for molecular medicine. It aims to provide information that can be useful to support ongoing research and work to improve diagnostics and therapeutics based on molecular–level insights.
- Open Access
- 1 January 2013
- Published by IOP Publishing in Computational Science & Discovery
- Vol. 6 (1) , 014011
Nanoinformatics knowledge infrastructures: bringing efficient information management to nanomedical research
Nanotechnology represents an area of particular promise and significant opportunity across multiple scientific disciplines. Ongoing nanotechnology research ranges from the characterization of nanoparticles and nanomaterials to the analysis and processing of experimental data seeking correlations between nanoparticles and their functionalities and side effects. Due to their special properties, nanoparticles are suitable for cellular-level diagnostics and therapy, offering numerous applications in medicine, e.g. development of biomedical devices, tissue repair, drug delivery systems and biosensors. In nanomedicine, recent studies are producing large amounts of structural and property data, highlighting the role for computational approaches in information management. While in vitro and in vivo assays are expensive, the cost of computing is falling. Furthermore, improvements in the accuracy of computational methods (e.g. data mining, knowledge discovery, modeling and simulation) have enabled effective tools to automate the extraction, management and storage of these vast data volumes. Since this information is widely distributed, one major issue is how to locate and access data where it resides (which also poses data-sharing limitations). The novel discipline of nanoinformatics addresses the information challenges related to nanotechnology research. In this paper, we summarize the needs and challenges in the field and present an overview of extant initiatives and efforts.
- 1 January 2013
- Published by IOP Publishing in Computational Science & Discovery
- Vol. 6 (1) , 014011
Open AccessNanoinformatics knowledge infrastructures: bringing efficient information management to nanomedical research
Nanotechnology represents an area of particular promise and significant opportunity across multiple scientific disciplines. Ongoing nanotechnology research ranges from the characterization of nanoparticles and nanomaterials to the analysis and processing of experimental data seeking correlations between nanoparticles and their functionalities and side effects. Due to their special properties, nanoparticles are suitable for cellular-level diagnostics and therapy, offering numerous applications in medicine, e.g. development of biomedical devices, tissue repair, drug delivery systems and biosensors. In nanomedicine, recent studies are producing large amounts of structural and property data, highlighting the role for computational approaches in information management. While in vitro and in vivo assays are expensive, the cost of computing is falling. Furthermore, improvements in the accuracy of computational methods (e.g. data mining, knowledge discovery, modeling and simulation) have enabled effective tools to automate the extraction, management and storage of these vast data volumes. Since this information is widely distributed, one major issue is how to locate and access data where it resides (which also poses data-sharing limitations). The novel discipline of nanoinformatics addresses the information challenges related to nanotechnology research. In this paper, we summarize the needs and challenges in the field and present an overview of extant initiatives and efforts.
- 1 January 2011
- Published by Georg Thieme Verlag KG in Methods of Information in Medicine
- Vol. 50 (01) , 84-95
International Efforts in Nanoinformatics Research Applied to Nanomedicine
Summary: Background: Nanomedicine and nanoinformatics are novel disciplines facing substantial challenges. Since nanomedicine involves complex and massive data analysis and management, a new discipline named nanoinformatics is now emerging to provide the vision and the informatics methods and tools needed forsuch purposes. Methods from biomedical informatics may prove applicable with some adaptation despite nanomedicine involving different biophysical and biochemical characteristics of nanomaterials and corresponding differences in information complexity. Objectives: We analyze recent initiatives and opportunities for research in nanomedicine and nanoinformatics as well as the previous experience of the authors, particularly in the context of a European project named ACTION-Grid. In this project the authors aimed to create a collaborative environment in biomedical and nanomedical research among countries in Europe, Western Balkans, Latin America, North Africa and the USA. Methods: We review and analyze the rationale and scientific issues behind the new fields of nanomedicine and nanoinformatics. Such a review is linked to actual research projects and achievements of the authors within their groups. Results: The work of the authors at the intersection between these two areas is presented. We also analyze several research initiatives that have recently emerged in the EU and USA context and highlight some ideas for future action at the international level. Conclusions: Nanoinformatics aims to build new bridges between medicine, nanotechnology and informatics, allowing the application of computational methods in the nano-related areas. Opportunities for world-wide collaboration are already emerging and will be influential in advancing the field.
- 1 January 2011
- Published by Georg Thieme Verlag KG in Methods of Information in Medicine
- Vol. 50 (01) , 84-95
International Efforts in Nanoinformatics Research Applied to Nanomedicine
Summary: Background: Nanomedicine and nanoinformatics are novel disciplines facing substantial challenges. Since nanomedicine involves complex and massive data analysis and management, a new discipline named nanoinformatics is now emerging to provide the vision and the informatics methods and tools needed forsuch purposes. Methods from biomedical informatics may prove applicable with some adaptation despite nanomedicine involving different biophysical and biochemical characteristics of nanomaterials and corresponding differences in information complexity. Objectives: We analyze recent initiatives and opportunities for research in nanomedicine and nanoinformatics as well as the previous experience of the authors, particularly in the context of a European project named ACTION-Grid. In this project the authors aimed to create a collaborative environment in biomedical and nanomedical research among countries in Europe, Western Balkans, Latin America, North Africa and the USA. Methods: We review and analyze the rationale and scientific issues behind the new fields of nanomedicine and nanoinformatics. Such a review is linked to actual research projects and achievements of the authors within their groups. Results: The work of the authors at the intersection between these two areas is presented. We also analyze several research initiatives that have recently emerged in the EU and USA context and highlight some ideas for future action at the international level. Conclusions: Nanoinformatics aims to build new bridges between medicine, nanotechnology and informatics, allowing the application of computational methods in the nano-related areas. Opportunities for world-wide collaboration are already emerging and will be influential in advancing the field.
- Open Access
- 3 August 2010
- Published by Springer Nature in BMC Bioinformatics
- Vol. 11 (1) , 410
A method for automatically extracting infectious disease-related primers and probes from the literature
Primer and probe sequences are the main components of nucleic acid-based detection systems. Biologists use primers and probes for different tasks, some related to the diagnosis and prescription of infectious diseases. The biological literature is the main information source for empirically validated primer and probe sequences. Therefore, it is becoming increasingly important for researchers to navigate this important information. In this paper, we present a four-phase method for extracting and annotating primer/probe sequences from the literature. These phases are: (1) convert each document into a tree of paper sections, (2) detect the candidate sequences using a set of finite state machine-based recognizers, (3) refine problem sequences using a rule-based expert system, and (4) annotate the extracted sequences with their related organism/gene information.
- 3 August 2010
- Published by Springer Nature in BMC Bioinformatics
- Vol. 11 (1) , 410
Open AccessA method for automatically extracting infectious disease-related primers and probes from the literature
Primer and probe sequences are the main components of nucleic acid-based detection systems. Biologists use primers and probes for different tasks, some related to the diagnosis and prescription of infectious diseases. The biological literature is the main information source for empirically validated primer and probe sequences. Therefore, it is becoming increasingly important for researchers to navigate this important information. In this paper, we present a four-phase method for extracting and annotating primer/probe sequences from the literature. These phases are: (1) convert each document into a tree of paper sections, (2) detect the candidate sequences using a set of finite state machine-based recognizers, (3) refine problem sequences using a rule-based expert system, and (4) annotate the extracted sequences with their related organism/gene information.
- Open Access
- 7 October 2009
- Published by Springer Nature in BMC Bioinformatics
- Vol. 10 (1) , 320
BIRI: a new approach for automatically discovering and indexing available public bioinformatics resources from the literature
The rapid evolution of Internet technologies and the collaborative approaches that dominate the field have stimulated the development of numerous bioinformatics resources. To address this new framework, several initiatives have tried to organize these services and resources. In this paper, we present the BioInformatics Resource Inventory (BIRI), a new approach for automatically discovering and indexing available public bioinformatics resources using information extracted from the scientific literature. The index generated can be automatically updated by adding additional manuscripts describing new resources. We have developed web services and applications to test and validate our approach. It has not been designed to replace current indexes but to extend their capabilities with richer functionalities.
- 7 October 2009
- Published by Springer Nature in BMC Bioinformatics
- Vol. 10 (1) , 320
Open AccessBIRI: a new approach for automatically discovering and indexing available public bioinformatics resources from the literature
The rapid evolution of Internet technologies and the collaborative approaches that dominate the field have stimulated the development of numerous bioinformatics resources. To address this new framework, several initiatives have tried to organize these services and resources. In this paper, we present the BioInformatics Resource Inventory (BIRI), a new approach for automatically discovering and indexing available public bioinformatics resources using information extracted from the scientific literature. The index generated can be automatically updated by adding additional manuscripts describing new resources. We have developed web services and applications to test and validate our approach. It has not been designed to replace current indexes but to extend their capabilities with richer functionalities.
- 1 January 2009
- Vol. 150, 757-61
European efforts in nanoinformatics research applied to nanomedicine.
Nanomedicine and nanoinformatics are emerging disciplines with substantial challenges ahead. For instance, nanomedicine involves complex and massive data analysis. Nanoinformatics could expand previous experiences in Biomedical Informatics with new features required to study different scientific biological and physical characteristics at a different level of complexity. ACTION-Grid is a project, funded by the European Commission, which aims to the creation of a collaborative environment in biomedical and nanomedical research among countries in Europe, Western Balkans, Latin America and North Africa. In this paper, we briefly review the concepts of nanomedicine and nanoinformatics and then we describe the activities of some of the ACTION-Grid consortium members considering those initiatives related to nanomedicine.
- 1 January 2009
- Vol. 150, 757-61
European efforts in nanoinformatics research applied to nanomedicine.
Nanomedicine and nanoinformatics are emerging disciplines with substantial challenges ahead. For instance, nanomedicine involves complex and massive data analysis. Nanoinformatics could expand previous experiences in Biomedical Informatics with new features required to study different scientific biological and physical characteristics at a different level of complexity. ACTION-Grid is a project, funded by the European Commission, which aims to the creation of a collaborative environment in biomedical and nanomedical research among countries in Europe, Western Balkans, Latin America and North Africa. In this paper, we briefly review the concepts of nanomedicine and nanoinformatics and then we describe the activities of some of the ACTION-Grid consortium members considering those initiatives related to nanomedicine.
- 1 January 2009
- Vol. 150, 987-91
Nanoinformatics: new challenges for biomedical informatics at the nano level.
Over the last decades Nanotechnology has promised to advance science and technology in many areas. Within medicine, Nanomedicine promises to deliver new methods for diagnosis, prognosis and therapy. As the amount of available information is rapidly growing, new Biomedical Informatics approaches have to be developed to satisfy the increasing demand on data and knowledge management. In 2007, a new sub-discipline, already named "Nanoinformatics", was created with support from the US National Science Foundation. In Europe, a project named ACTION-Grid was launched in 2008 with support from the European Commission to analyze the challenges and agenda for developing Nanoinformatics as a discipline related to Nanotechnology, Biomedicine and Informatics. For MIE 2009, members of this consortium proposed a workshop to discuss the scientific and strategic issues associated with this topic. Nanoinformatics aims to create a bridge between Nanomedicine and Information Technology applying computational methods to manage the information created in the nanomedical domain.
- 1 January 2009
- Vol. 150, 987-91
Nanoinformatics: new challenges for biomedical informatics at the nano level.
Over the last decades Nanotechnology has promised to advance science and technology in many areas. Within medicine, Nanomedicine promises to deliver new methods for diagnosis, prognosis and therapy. As the amount of available information is rapidly growing, new Biomedical Informatics approaches have to be developed to satisfy the increasing demand on data and knowledge management. In 2007, a new sub-discipline, already named "Nanoinformatics", was created with support from the US National Science Foundation. In Europe, a project named ACTION-Grid was launched in 2008 with support from the European Commission to analyze the challenges and agenda for developing Nanoinformatics as a discipline related to Nanotechnology, Biomedicine and Informatics. For MIE 2009, members of this consortium proposed a workshop to discuss the scientific and strategic issues associated with this topic. Nanoinformatics aims to create a bridge between Nanomedicine and Information Technology applying computational methods to manage the information created in the nanomedical domain.
- Open Access
- 1 January 2009
- Published by IOS Press
- p. 987-991
Nanoinformatics: New Challenges for Biomedical Informatics at the Nano Level
Over the last decades Nanotechnology has promised to advance science and technology in many areas. Within medicine, Nanomedicine promises to deliver new methods for diagnosis, prognosis and therapy. As the amount of available information is rapidly growing, new Biomedical Informatics approaches have to be developed to satisfy the increasing demand on data and knowledge management. In 2007, a new sub-discipline, already named “Nanoinformatics”, was created with support from the US National Science Foundation. In Europe, a project named ACTION-Grid was launched in 2008 with support from the European Commission to analyze the challenges and agenda for developing Nanoinformatics as a discipline related to Nanotechnology, Biomedicine and Informatics. For MIE 2009, members of this consortium proposed a workshop to discuss the scientific and strategic issues associated with this topic. Nanoinformatics aims to create a bridge between Nanomedicine and Information Technology applying computational methods to manage the information created in the nanomedical domain.
- 1 January 2009
- Published by IOS Press
- p. 987-991
Open AccessNanoinformatics: New Challenges for Biomedical Informatics at the Nano Level
Over the last decades Nanotechnology has promised to advance science and technology in many areas. Within medicine, Nanomedicine promises to deliver new methods for diagnosis, prognosis and therapy. As the amount of available information is rapidly growing, new Biomedical Informatics approaches have to be developed to satisfy the increasing demand on data and knowledge management. In 2007, a new sub-discipline, already named “Nanoinformatics”, was created with support from the US National Science Foundation. In Europe, a project named ACTION-Grid was launched in 2008 with support from the European Commission to analyze the challenges and agenda for developing Nanoinformatics as a discipline related to Nanotechnology, Biomedicine and Informatics. For MIE 2009, members of this consortium proposed a workshop to discuss the scientific and strategic issues associated with this topic. Nanoinformatics aims to create a bridge between Nanomedicine and Information Technology applying computational methods to manage the information created in the nanomedical domain.